Pharmaceutical Isolator Market
Pharmaceutical Isolator Market Forecasts to 2030 - Global Analysis By Type (Aseptic Isolators, Containment Isolators, Bio Isolators, Sampling And Weighing Isolators and Other Types), System Type (Closed System and Open System), Pressure, Configuration, Distribution Channel, Application, End User and by Geography
Years Covered |
2021-2030 |
Estimated Year Value (2023) |
US $12.45 BN |
Projected Year Value (2030) |
US $24.82 BN |
CAGR (2023 - 2030) |
10.36% |
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
Largest Market |
North America |
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Pharmaceutical Isolator Market is accounted for $12.45 billion in 2023 and is expected to reach $24.82 billion by 2030 growing at a CAGR of 10.36% during the forecast period. Pharmaceutical isolators are employed as a barrier system that prevents contamination. Pharmaceutical isolators are used in a variety of industries, including microbiological testing, cell therapy processing, advanced pharmaceutical manufacturing (ATMP) and the weighing, packaging, and distribution of sterile injectable products.
According to the Pharmaceutical Research and Manufacturers of America data updates from September 2021, since 2000, PhRMA member companies have invested more than USD 1.1 Trillion in the search for new treatments and cures, including USD 102.3 Billion in 2021 alone.
Market Dynamics:
Driver:
Growing requirement for pharmacological sterile procedures
The increasing recognition of the vital role cleanliness plays in the production of pharmaceuticals is driving the demand for sterile pharmaceutical processes. Isolators become essential instruments as pharmaceutical companies work to provide the best possible drugs. Moreover, pharmaceutical products are kept pure and undamaged thanks to these carefully monitored settings that are outfitted with cutting-edge containment and air filtration systems.
Restraint:
Budgetary restrictions and upfront investment
Pharmaceutical isolators have many advantages, such as regulatory compliance and contamination control, but their installation is expensive up front. However, some pharmaceutical companies may find it difficult to afford the costs involved in designing, installing, and validating isolator systems, particularly smaller ones or those with more restricted funding. Despite the long-term benefits that isolators offer, this financial barrier may prevent widespread adoption.
Opportunity:
Technological developments in isolators
Pharmaceutical companies have a lot of potential thanks to ongoing advancements in isolator technology. Innovations that contribute to the development of isolator solutions include better containment systems, improved material designs, and more user-friendly interfaces. Moreover, businesses in the isolator technology sector that make research and development investments stand to benefit from a competitive advantage by providing cutting-edge solutions that solve existing issues and fit the changing demands of the market.
Threat:
Rising alternative technologies for containment
The dominant position of pharmaceutical isolators in the market is under threat from the emergence of alternative solutions in the dynamic landscape of containment technologies. For some applications, advanced barrier technologies, robotic systems, or alternatives to closed-system processing may be viable options that draw attention and funding away from conventional isolator solutions. Additionally, manufacturers of isolators must constantly innovate and highlight the distinctive value proposition of their goods in order to lessen this threat.
Covid-19 Impact:
The pharmaceutical isolator market has been impacted by the COVID-19 pandemic in many ways. The demand for pharmaceutical isolators has been fueled by the pandemic's increased focus on drug development and healthcare, but there have been obstacles due to workforce shortages, global supply chain disruptions, and uncertain economic conditions. Furthermore, the pandemic has highlighted the significance of flexible and agile manufacturing processes, leading businesses to reevaluate and improve their containment plans. This could spur innovation in the pharmaceutical isolator market in the aftermath of the pandemic.
The Floor-standing segment is expected to be the largest during the forecast period
Due to its prominence in offering ample workspace and flexibility for a variety of manufacturing processes, the floor-standing segment holds the largest share of the pharmaceutical isolator market. With room for larger equipment and the ability to support ergonomic workflows, floor-standing isolators provide large spaces for intricate operations. Moreover, these are appropriate for a wide range of applications, including high-potency drug manufacturing and aseptic processing, due to their versatility. Complex control systems, material pass-through systems, and integrated glove ports are just a few examples of the advanced features that these isolators frequently incorporate.
The Contract Research Organizations segment is expected to have the highest CAGR during the forecast period
Contract Research Organizations (CROs) are the market segment with the highest CAGR. CROs are essential to the biotechnology and pharmaceutical industries because they offer specialized services for research and development. The need for sophisticated laboratory equipment, including cutting-edge diagnostic tools and instruments, has increased due to the trend of outsourcing drug development and clinical trials. Furthermore, CROs use academic institutions, research centers, and diagnostic labs to carry out extensive studies that promote the uptake of cutting-edge technologies.
Region with largest share:
Due to its strong healthcare system, large R&D expenditures, and strict regulatory requirements, North America presently commands the largest share of the market for pharmaceutical isolators. The numerous contract research organizations and the pharmaceutical and biotechnology companies that operate in the area have a significant impact on the demand for isolator systems. Moreover, a proactive approach to implementing state-of-the-art technologies and a strong focus on upholding the highest standards of product quality and safety add to the prevalence of pharmaceutical isolators in North America.
Region with highest CAGR:
The Asia-Pacific-Pacific has the highest CAGR in the market, driven by dynamic developments in the biotechnology and pharmaceutical industries. Increased investments in healthcare infrastructure, a growing focus on research and development, and a surge in drug development activities are all occurring in the region. Additionally, the market for pharmaceutical isolators is growing due to a number of factors, including a large patient population, rising healthcare costs, and a supportive regulatory framework.
Key players in the market
Some of the key players in Pharmaceutical Isolator market include Getinge AB, Fedegari Autoclavi S.p.A, Azbil Corporation, Schematic Engineering Industries, Germfree Laboratories, Inc., Chiyoda Corporation, Hosokawa Micron B.V, Bioquell Inc., NuAire Inc, Hecht Technologie Gmbh, Comecer S.P.A, Skan AG, M. Braun Inertgas-Systeme Gmbh, Tema Sinergie S.P.A, Chamunda Pharma Machinery Pvt. Ltd and Isotech Design.
Key Developments:
In October 2023, Azbil Corporation has announced an investment agreement with Forest Energy Inc., headquartered in Tokyo. To support the realization of a sustainable society powered by renewable energy, Azbil is underwriting Forest Energy’s third-party allocation of Renewable Energynew shares.
In October 2023, Germfree Laboratories and Title21 Health Solutions unveil a groundbreaking mobile manufacturing platform seamlessly integrated with an advanced manufacturing operating system, set to redefine decentralized point-of-care (POC) cell and gene therapy production. This partnership focuses on decentralized manufacturing, an innovative approach to traditional centralized models, aiming to overcome bottlenecks and streamline access to therapy delivery.
In May 2023, Getinge announces an agreement to acquire 100% of the shares in High Purity New England, Inc. a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. This acquisition is another step in Getinge Life Science strategic journey to further expand our presence in the biopharma segment, says Eric Honroth, President Life Science at Getinge.
Types Covered:
• Aseptic Isolators
• Containment Isolators
• Bio Isolators
• Sampling And Weighing Isolators
• Active Pharmaceutical Ingredient (API) Manufacturing Isolators
• Radiopharmaceutical Isolators
• Fluid Dispensing Isolators
• Production Isolators
• Other Types
System Types Covered:
• Closed System
• Open System
Pressures Covered:
• Positive Pressure
• Negative Pressure
Configurations Covered:
• Floor Standing
• Modular
• Mobile
• Compact
• Table Top
• Portable
• Other Configurations
Distribution Channels Covered:
• Direct Tender
• Retail Sales
• Third Party Distributors
Applications Covered:
• Sterility Testing
• Sampling/ Weighing/ Distribution
• Medical Device Manufacturing
• Other Applications
End Users Covered:
• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Pharmaceutical Isolator Market, By Type
5.1 Introduction
5.2 Aseptic Isolators
5.3 Containment Isolators
5.4 Bio Isolators
5.5 Sampling And Weighing Isolators
5.6 Active Pharmaceutical Ingredient (API) Manufacturing Isolators
5.7 Radiopharmaceutical Isolators
5.8 Fluid Dispensing Isolators
5.9 Production Isolators
5.10 Other Types
6 Global Pharmaceutical Isolator Market, By System Type
6.1 Introduction
6.2 Closed System
6.3 Open System
7 Global Pharmaceutical Isolator Market, By Pressure
7.1 Introduction
7.2 Positive Pressure
7.3 Negative Pressure
8 Global Pharmaceutical Isolator Market, By Configuration
8.1 Introduction
8.2 Floor Standing
8.3 Modular
8.4 Mobile
8.5 Compact
8.6 Table Top
8.7 Portable
8.8 Other Configuartions
9 Global Pharmaceutical Isolator Market, By Distribution Channel
9.1 Introduction
9.2 Direct Tender
9.3 Retail Sales
9.4 Third Party Distributors
10 Global Pharmaceutical Isolator Market, By Application
10.1 Introduction
10.2 Sterility Testing
10.3 Sampling/ Weighing/ Distribution
10.4 Medical Device Manufacturing
10.5 Other Applications
11 Global Pharmaceutical Isolator Market, By End User
11.1 Introduction
11.2 Hospitals
11.3 Diagnostic Laboratories
11.4 Academic and Research Institutes
11.5 Pharmaceutical and Biotechnology Companies
11.6 Contract Research Organizations
11.7 Other End Users
12 Global Pharmaceutical Isolator Market, By Geography
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 New Zealand
12.4.6 South Korea
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Argentina
12.5.2 Brazil
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 Qatar
12.6.4 South Africa
12.6.5 Rest of Middle East & Africa
13 Key Developments
13.1 Agreements, Partnerships, Collaborations and Joint Ventures
13.2 Acquisitions & Mergers
13.3 New Product Launch
13.4 Expansions
13.5 Other Key Strategies
14 Company Profiling
14.1 Getinge AB
14.2 Fedegari Autoclavi S.p.A
14.3 Azbil Corporation
14.4 Schematic Engineering Industries
14.5 Germfree Laboratories, Inc.
14.6 Chiyoda Corporation
14.7 Hosokawa Micron B.V
14.8 Bioquell Inc.
14.9 NuAire Inc
14.10 Hecht Technologie Gmbh
14.11 Comecer S.P.A
14.12 Skan AG
14.13 M. Braun Inertgas-Systeme Gmbh
14.14 Tema Sinergie S.P.A
14.15 Chamunda Pharma Machinery Pvt. Ltd
14.16 Isotech Design
List of Tables
1 Global Pharmaceutical Isolator Market Outlook, By Region (2021-2030) ($MN)
2 Global Pharmaceutical Isolator Market Outlook, By Type (2021-2030) ($MN)
3 Global Pharmaceutical Isolator Market Outlook, By Aseptic Isolators (2021-2030) ($MN)
4 Global Pharmaceutical Isolator Market Outlook, By Containment Isolators (2021-2030) ($MN)
5 Global Pharmaceutical Isolator Market Outlook, By Bio Isolators (2021-2030) ($MN)
6 Global Pharmaceutical Isolator Market Outlook, By Sampling And Weighing Isolators (2021-2030) ($MN)
7 Global Pharmaceutical Isolator Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing Isolators (2021-2030) ($MN)
8 Global Pharmaceutical Isolator Market Outlook, By Radiopharmaceutical Isolators (2021-2030) ($MN)
9 Global Pharmaceutical Isolator Market Outlook, By Fluid Dispensing Isolators (2021-2030) ($MN)
10 Global Pharmaceutical Isolator Market Outlook, By Production Isolators (2021-2030) ($MN)
11 Global Pharmaceutical Isolator Market Outlook, By Other Types (2021-2030) ($MN)
12 Global Pharmaceutical Isolator Market Outlook, By System Type (2021-2030) ($MN)
13 Global Pharmaceutical Isolator Market Outlook, By Closed System (2021-2030) ($MN)
14 Global Pharmaceutical Isolator Market Outlook, By Open System (2021-2030) ($MN)
15 Global Pharmaceutical Isolator Market Outlook, By Pressure (2021-2030) ($MN)
16 Global Pharmaceutical Isolator Market Outlook, By Positive Pressure (2021-2030) ($MN)
17 Global Pharmaceutical Isolator Market Outlook, By Negative Pressure (2021-2030) ($MN)
18 Global Pharmaceutical Isolator Market Outlook, By Configuration (2021-2030) ($MN)
19 Global Pharmaceutical Isolator Market Outlook, By Floor Standing (2021-2030) ($MN)
20 Global Pharmaceutical Isolator Market Outlook, By Modular (2021-2030) ($MN)
21 Global Pharmaceutical Isolator Market Outlook, By Mobile (2021-2030) ($MN)
22 Global Pharmaceutical Isolator Market Outlook, By Compact (2021-2030) ($MN)
23 Global Pharmaceutical Isolator Market Outlook, By Table Top (2021-2030) ($MN)
24 Global Pharmaceutical Isolator Market Outlook, By Portable (2021-2030) ($MN)
25 Global Pharmaceutical Isolator Market Outlook, By Other Configuartions (2021-2030) ($MN)
26 Global Pharmaceutical Isolator Market Outlook, By Distribution Channel (2021-2030) ($MN)
27 Global Pharmaceutical Isolator Market Outlook, By Direct Tender (2021-2030) ($MN)
28 Global Pharmaceutical Isolator Market Outlook, By Retail Sales (2021-2030) ($MN)
29 Global Pharmaceutical Isolator Market Outlook, By Third Party Distributors (2021-2030) ($MN)
30 Global Pharmaceutical Isolator Market Outlook, By Application (2021-2030) ($MN)
31 Global Pharmaceutical Isolator Market Outlook, By Sterility Testing (2021-2030) ($MN)
32 Global Pharmaceutical Isolator Market Outlook, By Sampling/ Weighing/ Distribution (2021-2030) ($MN)
33 Global Pharmaceutical Isolator Market Outlook, By Medical Device Manufacturing (2021-2030) ($MN)
34 Global Pharmaceutical Isolator Market Outlook, By Other Applications (2021-2030) ($MN)
35 Global Pharmaceutical Isolator Market Outlook, By End User (2021-2030) ($MN)
36 Global Pharmaceutical Isolator Market Outlook, By Hospitals (2021-2030) ($MN)
37 Global Pharmaceutical Isolator Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
38 Global Pharmaceutical Isolator Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
39 Global Pharmaceutical Isolator Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
40 Global Pharmaceutical Isolator Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
41 Global Pharmaceutical Isolator Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.